Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More
1 minute read

EXLUSIVE: SAB Biotherapeutics To Raise Up To $130M Via Preferred Equity To Advance Development Of Lead Diabetes Candidate

By Vandana Singh
October 2, 7:15 AM
SAB Biotherapeutics (NASDAQ: SABS) has entered into a securities purchase agreement with certain investors to issue and sell shares of preferred stock in a private placement of up to $130 million in gross proceeds.

SABS

Read More
3 minute read

EXCLUSIVE: Why Professionals With Mainstream Experience Are Crucial In The Cannabis Industry

By Jelena Martinovic
September 28, 7:51 PM
For the cannabis industry to continue to evolve and establish itself in the mainstream market, employing professionals with mainstream industry experience is vital, according to industry experts gathered at the Benzinga Cannabis Capital Conference.

CRLBF

Read More
3 minute read

The Rise Of The Northeastern Cannabis Market, Profitability And Inclusion At Benzinga Cannabis Capital Conference

By Nicolas Jose Rodriguez
September 28, 7:40 PM
As the Northeast U.S. cannabis market takes the lead in growth potential, questions arise on how the region can transform the industry playbook. Can collaboration between legacy operators and established companies pave the way for a thriving, profitable future?

ACRGF